Form 4 for LCTX Lineage Cell Therapeutics, Inc.
Accepted 2024-11-26 00:00:00 ET · period of report 2024-11-26 · accession 0000950170-24-131093 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-11-26 | 2024-11-26 | LCTX | Samuel George A. III | GC | P - Purchase | $0.6 | +15.0K | 22.2K | +209% | +$9,000 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares | 2024-11-26 | P | A | 15,000 | $0.6 | 22,184 | D | — | — |